Keywords: R&D spending, Research productivity, NME launches, Thomson Reuters, EIU

After recent R&D disappointments, pharma pipelines improving, says Thomson Reuters

Article | 27 June 2012

The pharmaceutical industry’s research productivity is finally improving after years of disappointment, as drugmakers shift their focus from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in